Literature DB >> 6198227

Human insulin: much ado about one amino acid?

G E Sonnenberg, M Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6198227     DOI： 10.1007/bf00284450

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  33 in total

1.  Generalised allergic reaction with synthetic human insulin.

Authors:  A O Carveth-Johnson; K Mylvaganam; D F Child
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

2.  Different counterregulatory responses to human insulin (recombinant DNA) and purified pork insulin.

Authors:  K J Schlüter; K G Petersen; J Sontheimer; F Enzmann; L Kerp
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

3.  Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months.

Authors:  I Mühlhauser; V Jörgens; M Berger; W Graninger; W Gürtler; L Hornke; A Kunz; G Schernthaner; V Scholz; H E Voss
Journal:  Diabetologia       Date:  1983-12       Impact factor: 10.122

4.  Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.

Authors:  F W Kemmer; G Sonnenberg; H J Cüppers; M Berger
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

5.  Immunologic improvement resulting from the transfer of animal insulin-treated diabetic subjects to human insulin (recombinant DNA).

Authors:  S E Fineberg; J A Galloway; N S Fineberg; M J Rathbun
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

6.  Comparative studies on intermediary metabolism and hormonal counterregulation following human insulin (recombinant DNA) and purified pork insulin in man.

Authors:  C Rosak; P H Althoff; F Enzmann; K Schöffling
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

7.  Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors.

Authors:  L M Keefer; M A Piron; P De Meyts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects.

Authors:  M Massi-Benedetti; J M Burrin; B Capaldo; K G Alberti
Journal:  Diabetes Care       Date:  1981 Mar-Apr       Impact factor: 19.112

9.  Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes.

Authors:  M A Charles; A Szekeres; M Staten; B Worcester; K M Walsh
Journal:  Diabetes Care       Date:  1983 Mar-Apr       Impact factor: 19.112

10.  Comparison of the biologic activity of porcine and semisynthetic human insulins using the glucose-controlled insulin infusion system in insulin-dependent diabetes.

Authors:  A Szekeres; B Worcester; M S Ascher; D Tuxen; R Heyendal; K M Walsh; M A Charles
Journal:  Diabetes Care       Date:  1983 Mar-Apr       Impact factor: 19.112
View more
  9 in total

1.  Human insulin and unawareness of hypoglycaemia: need for a large randomised trial.

Authors:  M Egger; G D Smith; A Teuscher
Journal:  BMJ       Date:  1992-08-08

2.  Re: Hypoglycaemia (un)awareness: human vs animal insulin.

Authors:  M Egger; A Teuscher; W G Berger
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

3.  Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.

Authors:  K Zuppinger; C Aebi; S Fankhauser; G Herz; R P Zurbrügg; K Schopfer; T M Neri
Journal:  Diabetologia       Date:  1987-12       Impact factor: 10.122

4.  Human insulin: much ado about hypoglycaemia (un)awareness.

Authors:  M Berger
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

Review 5.  Insulin: evolution of insulin formulations and their application in clinical practice over 100 years.

Authors:  Geremia B Bolli; Alice Y Y Cheng; David R Owens
Journal:  Acta Diabetol       Date:  2022-07-19       Impact factor: 4.087

6.  Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin.

Authors:  A S Luyckx; J C Daubresse; C Jaminet; A Scheen; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

7.  Production of genetically modified pigs expressing human insulin and C-peptide as a source of islets for xenotransplantation.

Authors:  Bumrae Cho; Eun-Jin Lee; Sun Mi Ahn; Ghangyong Kim; Sang Hoon Lee; Dal-Young Ji; Jung-Taek Kang
Journal:  Transgenic Res       Date:  2019-08-31       Impact factor: 2.788

8.  Influence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabetics.

Authors:  R S Gray; P Cowan; U di Mario; R A Elton; B F Clarke; L J Duncan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

Review 9.  Non-insulin-dependent (type II) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.